Literature DB >> 15988580

Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes.

N Ahmed1, R Babaei-Jadidi, S K Howell, P J Beisswenger, P J Thornalley.   

Abstract

AIMS/HYPOTHESIS: Hyperglycaemia in diabetes is associated with increased glycation, oxidative stress and nitrosative stress. Proteins modified consequently contain glycation, oxidation and nitration adduct residues, and undergo cellular proteolysis with release of corresponding free adducts. These free adducts leak into blood plasma for eventual renal excretion. The aim of this study was to perform a comprehensive quantitative analysis of protein glycation, oxidation and nitration adduct residues in plasma protein and haemoglobin as well as of free adducts in plasma and urine to quantify increased protein damage and flux of proteolytic degradation products in diabetes.
METHODS: Type 1 diabetic patients (n=21) and normal healthy control subjects (n=12) were studied. Venous blood samples, with heparin anticoagulant, and 24-h urine samples were taken. Samples were analysed for protein glycation, oxidation and nitration adducts by a quantitative comprehensive screening method using liquid chromatography with triple quadrupole mass spectrometric detection.
RESULTS: In type 1 diabetic patients, the concentrations of protein glycation, oxidation and nitration adduct residues increased up to three-fold in plasma protein and up to one-fold in haemoglobin, except for decreases in pentosidine and 3-nitrotyrosine residues in haemoglobin when compared with normal control subjects. In contrast, the concentrations of protein glycation and oxidation free adducts increased up to ten-fold in blood plasma, and urinary excretion increased up to 15-fold in diabetic patients. CONCLUSIONS/
INTERPRETATION: We conclude that there are profound increases in proteolytic products of glycated and oxidised proteins in diabetic patients, concurrent with much lower increases in protein glycation and oxidation adduct residues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15988580     DOI: 10.1007/s00125-005-1810-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  53 in total

Review 1.  Protein degradation and protection against misfolded or damaged proteins.

Authors:  Alfred L Goldberg
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

2.  Long-term evaluation of electrospray ionization mass spectrometric analysis of glycated hemoglobin.

Authors:  N B Roberts; A B Amara; M Morris; B N Green
Journal:  Clin Chem       Date:  2001-02       Impact factor: 8.327

3.  Acetone metabolism in humans during diabetic ketoacidosis.

Authors:  G A Reichard; C L Skutches; R D Hoeldtke; O E Owen
Journal:  Diabetes       Date:  1986-06       Impact factor: 9.461

4.  Formation of methylglyoxal and D-lactate in human red blood cells in vitro.

Authors:  S A Phillips; P J Thornalley
Journal:  Biochem Soc Trans       Date:  1993-05       Impact factor: 5.407

5.  Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation.

Authors:  L Virág; P Jagtap; E Szabó; J G Mabley; L Liaudet; A Marton; D G Hoyt; K G Murthy; A L Salzman; G J Southan; C Szabó
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

6.  Mass spectrometric monitoring of albumin in uremia.

Authors:  P J Thornalley; M Argirova; N Ahmed; V M Mann; O Argirov; A Dawnay
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

7.  Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity.

Authors:  Naila Ahmed; Darin Dobler; Mark Dean; Paul J Thornalley
Journal:  J Biol Chem       Date:  2004-11-22       Impact factor: 5.157

8.  Radioimmunoassay of glycated serum protein using monoclonal antibody to glucitollysine and coomassie-brilliant-blue-coated polystyrene beads.

Authors:  Y Yamamoto; Y Tahara; T Cha; Y Noma; M Fukuda; E Yamato; H Yoneda; F Hashimoto; C Ohboshi; M Hirota
Journal:  Diabetes Res       Date:  1989-05

9.  Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.

Authors:  Paul J Thornalley; Sinan Battah; Naila Ahmed; Nikolaos Karachalias; Stamatina Agalou; Roya Babaei-Jadidi; Anne Dawnay
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

Review 10.  Mechanisms of oxidative stress in diabetes: implications for the pathogenesis of vascular disease and antioxidant therapy.

Authors:  Subramaniam Pennathur; Jay W Heinecke
Journal:  Front Biosci       Date:  2004-01-01
View more
  60 in total

Review 1.  Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.

Authors:  Megan Jack; Douglas Wright
Journal:  Transl Res       Date:  2012-01-10       Impact factor: 7.012

Review 2.  Trends in advanced glycation end products research in diabetes mellitus and its complications.

Authors:  José D Méndez; Jianling Xie; Montserrat Aguilar-Hernández; Verna Méndez-Valenzuela
Journal:  Mol Cell Biochem       Date:  2010-03-23       Impact factor: 3.396

3.  Protective effects of pioglitazone against immunoglobulin deposition on heart of streptozotocin-induced diabetic rats.

Authors:  M Yuan; M Qiu; J Cui; X Zhang; P Zhang
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

4.  Relationship between free iron and glycated hemoglobin in uncontrolled type 2 diabetes patients associated with complications.

Authors:  Jeevan K Shetty; Mungli Prakash; Mohammad S Ibrahim
Journal:  Indian J Clin Biochem       Date:  2008-03-06

Review 5.  Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms.

Authors:  Alin Stirban; Thomas Gawlowski; Michael Roden
Journal:  Mol Metab       Date:  2013-12-07       Impact factor: 7.422

Review 6.  Pathways of the Maillard reaction under physiological conditions.

Authors:  Christian Henning; Marcus A Glomb
Journal:  Glycoconj J       Date:  2016-06-13       Impact factor: 2.916

7.  Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms.

Authors:  Alfredo Csibi; David Communi; Nathalie Müller; Serge P Bottari
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

8.  Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes.

Authors:  Beatriz Duran-Jimenez; Darin Dobler; Sarah Moffatt; Naila Rabbani; Charles H Streuli; Paul J Thornalley; David R Tomlinson; Natalie J Gardiner
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

9.  Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin.

Authors:  Naila Rabbani; Madhu Varma Chittari; Charles W Bodmer; Daniel Zehnder; Antonio Ceriello; Paul J Thornalley
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

10.  Quantification of Modified Tyrosines in Healthy and Diabetic Human Urine using Liquid Chromatography/Tandem Mass Spectrometry.

Authors:  Yoji Kato; Natsuko Dozaki; Toshiyuki Nakamura; Noritoshi Kitamoto; Akihiro Yoshida; Michitaka Naito; Masayasu Kitamura; Toshihiko Osawa
Journal:  J Clin Biochem Nutr       Date:  2008-12-27       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.